|Fastest Growing Market:||Asia Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The vitreoretinal surgery devices market is projected to register a CAGR of nearly 6.6% over the forecast period of 2022-2027.
The COVID-19 pandemic led to disruption in not only the research and development activities of other therapies and drugs for medical conditions other than COVID-19 but also impacted the treatment procedures and supply chain of the pharmaceuticals and medical devices around the world which also impacted the studied market of vitreoretinal surgery devices market as the demand of these devices reduced due to reduction in the surgical procedures. For instance, as per the research study published in July 2021, titled “Impact on Visual Acuity in Neovascular Age-Related Macular Degeneration (nAMD) in Europe. Due to COVID-19 Pandemic Lockdown”, about 62.82% of patients that were on scheduled clinic visits and/or intravitreal injection treatment during the 3 months before the quarantine did not attend either to visit or for treatment during the lockdown which led to the significant decline in the mean number of the treatment for nAMD. Thus, COVID-19 had its impact on the studied market but with the decreasing number of COVID-19 cases and wide-scale vaccination programs, it is expected that the studied market will regain its full potential over years to pre-COVID-19 level.
The increasing incidence of eye disorders such as macular degeneration, diabetic retinopathy, macular holes, and others around the world are increasing the demand of the vitreoretinal surgery devices and thus, the studied market is expected to grow over the forecast period of the study. For instance, according to the research study published in November 2019 by Jeany Q.Li et. al., the pooled prevalence of early or intermediate age-related macular degeneration (AMD) and any late AMD in those 60 years and older was 25.3% and 2.4%, respectively, and it was observed that the prevalence was higher in the older population. Also, as per the same study, there were about 67 million people in the European Union were currently affected by the AMD which is further expected to increase to 77 million by 2050, primarily due to the ageing population in the region, and thus, the demand of vitreoretinal surgery devices is expected to increase as the demand for treatment increases and the studied market will grow.
The other major retina associated diseases is diabetic retinopathy whose prevalence is increasing very rapidly owing to the high prevalence of diabetes among population of world and is expected to have a significant impact on the vitreoretinal surgery market over the years. For instance, according to the research study published in May 2021 by Zhen Ling Teo et. al., diabetic retinopathy remains a common complication of DM and a leading cause of preventable blindness in the adult working population, and among the people with diabetes mellitus, the prevalence of diabetic retinopathy was 22.27%, 6.17% for vision-threatening diabetes mellitus (VTDR), and 4.07% for clinically significant macular edema (CSME).
Furthermore, many eye disorders are age-associated like macular degeneration and with the growing global geriatric population, the burden of eye diseases are further expected to increase which will augment the growth of the studied market. For instance, according to the World Population Ageing Highlight 2020 report published by United Nations, the geriatric population is expected to be double by 2050 and it is expected by 2050, the total global geriatric population would be 1.5 billion as compared to 727 million in 2020. However, side-effects associated with the vitreoretinal surgery is expected to impede the growth of the studied market over the forecast period of the study.
Scope of the Report
As per the scope of the report, vitreoretinal surgery devices are used to conduct surgeries for diseases like macular degeneration, retinal detachment, uveitis, vitreous hemorrhage, macular hole, and epiretinal membrane, retinal detachment, and complications related to diabetic retinopathy.
The vitreoretinal surgery devices market is segmented by product type (perfluorocarbon liquids, endoillumination instruments, vitreoretinal prefilled silicone oil syringes, and others), surgery type (anterior vitreoretinal surgery and posterior vitreoretinal surgery), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
|By Product Type|
|Perfluoro Carbon Liquids|
|Vitreoretinal Prefilled Silicone Oil Syringes|
|By Surgery Type|
|Anterior Vitreoretinal Surgery|
|Posterior Vitreoretinal Surgery|
Key Market Trends
Posterior Vitreoretinal Surgery is Expected to Hold a Significant Market Share Over the Forecast Period
The high prevalence of diseases/disorders associated with the posterior segment of the eye such as macular degeneration, posterior vitreous detachment, and others are driving the demand for posterior vitrectomy (surgical procedures used to treat diseases associated with retina and vitreous) which is expected to have a significant impact on the growth of posterior vitreoretinal surgery segment and the segment will grow. For instance, according to the research study published in September 2020, titled “Cutting-edge advances in therapy for the posterior segment of the eye: Solid lipid nanoparticles and nanostructured lipid carriers”, posterior segment eye diseases can result in severe vision loss, and it affects more than 300 million people around the world, which shows a significant burden of the disorders around the world.
Further, according to the research study published in July 2021 by Haifa A. Madi and Johannes Keller, the number of retinal detachments with breaks in England increased from 3,447 in 2000 to 10,971 in 2018, and the number of tractional retinal displacement increased from 290 in 2000 to 910 in 2018. Further, the same source reported that the number of reported pars plana vitrectomies irrespective of indication increased over fourfold from 5,761 to 26,900 in between 2000 to 2018 and it was concluded that the frequency of admission in hospital of England for surgically treated retinal detachment increasing since 2000. This data shows a increase in number of the posterior vitreoretinal surgery owing to the rising burden of eye disorders associated with the posterior segment of eye. Hence, the posterior vitreoretinal surgery segment is expected to have a major share in the vitreoretinal surgery devices market.
Also, the anterior vitrectomy procedures are uncommon as in very rare cases, the vitreous gel comes through the pupil into the anterior (front) chamber of the eye and thus, the posterior vitreoretinal surgery segment is expected to have a major share in the studied market over the forecast period of the study. Moreover, the emergence of COVID-19 pandemic negatively affected the eye surgery procedures around the world due to the closure of institutions or suspension of procedures.
To understand key trends, Download Sample Report
North America is Expected to Dominate the Vitreoretinal Surgery Devices Market Over the Forecast Period
North America dominates the vitreoretinal surgery devices market and is expected to show a similar trend over the forecast period, owing to the high prevalence and burden of eye diseases in the region, and the increasing geriatric population in the region. For instance, according to the report published in February 2021 in Fighting Blindness Canada stated that the prevalence of Age-related macular degeneration (AMD) is the most common cause of vision loss in people over 50 which shows that the AMD prevalence is higher in the older population and thus, the growing aging population in the region is expected to increase the burden of eye diseases, as the geriatric population is more prone to various diseases due to low immune response and decreasing neural capacity. For instance, according to the World Population Ageing Highlight report of 2019 published by the United Nations, in 2019, the United States geriatric (aged 65 years and more) population was about 53.3 million; 6.6 million in Canada, and 9.5 million in Mexico, and by 2050, it is projected to increase to 26.4 million in Mexico, 11.4 million in Canada, and 84.8 million in the United States which is anticipated to have a significant impact on the growth of the studied market in the North America region.
Moreover, in North America, the United States is expected to hold a major market share in the vitreoretinal surgery devices market during the forecast period due to the high prevalence of eye diseases/disorder, presence of robust healthcare infrastructure and Medicare, and increasing geriatric population in the country. For instance, according to the data published by Centers for Disease Control and Prevention (CDC) in 2020 around 4.1 million Americans are affected with diabetic retinopathy, and nearly 900,000 Americans are threatened with vision-damaging retinopathy, and as diabetic retinopathy is one of the leading disorders of posterior segment eye disorders, the increasing burden of diabetic retinopathy is expected to fuel the demand of better treatment procedures involving surgery and thus, the studied market will grow with the rise in number of surgical procedures in the country.
Further, age-related macular degeneration (AMD) is one of the more severe and prevalent eye diseases in the country and as per the article published by F. Ryan Prall in June 2021, in the United States, AMD is responsible for irreversible vision loss in more than 10% of the population of age 65-74 years and about 25% of the population that is older than 74 years in the country. Therefore, due to these factors, the demand for vitreoretinal surgery devices is expected to increase in the country and the studied market will grow during the forecast period of the study.
To understand geography trends, Download Sample Report
The Vitreoretinal Surgery Devices market is moderately competitive. A few of the crucial approaches followed by players functioning in the market are product advancement, invention, acquisitions, and mergers. Some of the key companies operating in the market are Dutch Ophthalmic Research Center International BV, Bausch & Lomb, Inc., OCULUS Optikgeräte GmbH, Paragon Care Group Australia Pty Ltd, and MedOne Surgical, Inc.
- In March 2022, Dutch Ophthalmic Research Center (International) B.V. launched EVA NEXUS, which features SmartIOP - a highly responsive infusion system for cataract surgery, enabling surgeons to work at lower infusion pressures and sustain a stable anterior chamber even in challenging cases.
- June 2021, Alcon Inc., hosted the fourth annual Alcon Retina Fellows Institute. The Retina Fellows Institute aims to expand the traditional surgical teaching paradigm, offering small group expert guidance from world-class faculty to first-year retina fellows.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Eye Disorders
4.2.2 Increasing Geriatric Population
4.3 Market Restraints
4.3.1 Side Effects of the Procedures
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Perfluoro Carbon Liquids
5.1.2 Endoillumination Instruments
5.1.3 Vitreoretinal Prefilled Silicone Oil Syringes
5.2 By Surgery Type
5.2.1 Anterior Vitreoretinal Surgery
5.2.2 Posterior Vitreoretinal Surgery
5.3.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.3.4 Middle East and Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East and Africa
5.3.5 South America
126.96.36.199 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Dutch Ophthalmic Research Center International BV
6.1.2 Bausch & Lomb, Inc.
6.1.3 OCULUS Optikgerete GmbH
6.1.4 Paragon Care Group Australia Pty Ltd
6.1.5 MedOne Surgical, Inc
6.1.7 Carl Zeiss
6.1.8 Topcon Corporation
6.1.9 Peregrine Surgical
6.1.10 Hoya Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Vitreoretinal Surgery Devices Market market is studied from 2019 - 2027.
What is the growth rate of Vitreoretinal Surgery Devices Market?
The Vitreoretinal Surgery Devices Market is growing at a CAGR of 6.6% over the next 5 years.
Which region has highest growth rate in Vitreoretinal Surgery Devices Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Vitreoretinal Surgery Devices Market?
North America holds highest share in 2021.
Who are the key players in Vitreoretinal Surgery Devices Market?
Dutch Ophthalmic Research Center International BV, Bausch & Lomb, Inc, Alcon, Inc., Carl Zeiss, MedOne Surgical, Inc are the major companies operating in Vitreoretinal Surgery Devices Market.